Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Nonwarfarin Anticoagulated Atrial Fibrillation Patients

Study Questions:

What is the relative performance of the HEMORR2HAGES, ATRIA, and HAS-BLED bleeding risk–prediction scores in patients anticoagulated for stroke prevention in atrial fibrillation with nonwarfarin anticoagulants?